Novacyt Group Revenue and Competitors

France

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Novacyt Group's estimated annual revenue is currently $17.2M per year.(i)
  • Novacyt Group's estimated revenue per employee is $155,000

Employee Data

  • Novacyt Group has 111 Employees.(i)
  • Novacyt Group grew their employee count by -15% last year.

Novacyt Group's People

NameTitleEmail/Phone
1
Head Human ResourcesReveal Email/Phone
2
Head QARA & Clinical AffairsReveal Email/Phone
3
Head Tech SupportReveal Email/Phone
4
Head BioinformaticsReveal Email/Phone
5
Head Human ResourcesReveal Email/Phone
6
Chief Operating OfficerReveal Email/Phone
7
Global Key Account ManagerReveal Email/Phone
8
Supply Chain & Operations Manager at Novacyt Group StokesleyReveal Email/Phone
9
Sales Manager LATAMReveal Email/Phone
10
Finance ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M81-5%N/AN/A
#2
$19.5M126-2%N/AN/A
#3
$36.3M23422%N/AN/A
#4
$19.7M127-17%N/AN/A
#5
$14.3M920%$179.5MN/A
#6
$49.4M208-8%€201.1MN/A
#7
$44.5M287-3%N/AN/A
#8
$7.6M49N/AN/AN/A
#9
$6.4M41N/AN/AN/A
#10
$17.2M111-15%N/AN/A
Add Company

What Is Novacyt Group?

Novacyt is an innovative high growth diagnostic group of companies founded in 2005 and focused on the design, manufacture and supply of a growing portfolio of oncology and infectious disease diagnostic products. Our Brands include: Primerdesign real-time molecular kits and reagents. Molecular genesig - molecular testing made simple. NovaPrep liquid based cytology for gynecology and non-gynecology cancer management. Microgen Bioproducts a provider of microbiological diagnostic products to the clinical and food industry. Biotec and Plasmatec a leading supplier of infectious disease tests primarily focused in developing markets. Lab 21 Clinical laboratory specialist molecular personalised medicine services supporting Healthcare providers, Biotec and Pharamceutical manufacturers. We are passionate about our business and the healthcare industry sector we work with and would like to thank you for your interest in Novacyt.

keywords:N/A

N/A

Total Funding

111

Number of Employees

$17.2M

Revenue (est)

-15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Novacyt Group News

2022-04-20 - Blood Group Typing Market Size Demonstrates Immense ...

... Novacyt Group, Ortho Clinical Diagnostics, DIAGAST, and Agena Bioscience. Market Analysis and Insights: Global Blood Group Typing Market...

2022-04-17 - Blood Group Typing Market Size And Forecast | Bio-Rad ...

Bio-Rad Laboratories Beckman Coulter (A Subsidiary of Danaher), Grifols International, S.A., Immucor Merck KGaA, Novacyt Group, Quotient,...

2022-04-13 - Novacyt PCR COVID-19 test approved under CTDA legislation

David Allmond, group CEO of Novacyt, commented: “Providing total viral inactivation without the need for a category 2 laboratory to handle...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$28.1M111N/AN/A
#2
$24.4M11111%N/A
#3
$30M111-11%N/A
#4
$36.4M111-9%N/A
#5
$15M1119%N/A